Federal workplaces would be required to stock overdose reversal drugs under HR 7479

What does this do?

HR 7479 directs OSHA to publish voluntary guidance for private employers on stocking and maintaining opioid overdose reversal medication, such as naloxone, and to encourage optional annual worker training. Separately, the bill legally requires every federal agency to keep overdose reversal medication on hand and to offer voluntary annual training to employees. Both actions must occur within 270 days of the bill becoming law.

Who does it affect?

Federal government workers across all agencies, including the Veterans Health Administration, would be directly covered by the mandatory requirement. Private-sector employers and their workers face no new legal obligations, though official guidance would be available to them; the United States Postal Service is specifically excluded from the private-employer guidance section.

Why does it matter?

Opioid overdoses remain a leading cause of accidental death in the United States, and the bill is aimed at improving workplace preparedness to respond to them. Federal workplaces would see a guaranteed change in available resources, while the effect on private workplaces would depend entirely on voluntary employer decisions.

Where does it stand?